...
bdsx-img

Biodesix Inc, Common Stock

BDSX

NMQ

$1.34

-$0.05

(-3.6%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$202.20M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
272.36K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.21
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.11 L
$2.21 H
$1.34

About Biodesix Inc, Common Stock

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameBDSXSectorS&P500
1-Week Return3.08%-2.06%-0.55%
1-Month Return6.35%-1.92%2.72%
3-Month Return-22.99%-10.4%7.66%
6-Month Return-16.77%-4.6%10.15%
1-Year Return-19.28%4.06%27.53%
3-Year Return-69.61%1.94%32.31%
5-Year Return-89.54%36.48%89.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue24.55M45.56M54.51M38.21M49.09M[{"date":"2019-12-31","value":45.04,"profit":true},{"date":"2020-12-31","value":83.58,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.11,"profit":true},{"date":"2023-12-31","value":90.06,"profit":true}]
Cost of Revenue6.07M22.00M30.52M14.15M13.01M[{"date":"2019-12-31","value":19.9,"profit":true},{"date":"2020-12-31","value":72.08,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":46.38,"profit":true},{"date":"2023-12-31","value":42.63,"profit":true}]
Gross Profit18.48M23.56M23.99M24.06M36.08M[{"date":"2019-12-31","value":51.22,"profit":true},{"date":"2020-12-31","value":65.3,"profit":true},{"date":"2021-12-31","value":66.49,"profit":true},{"date":"2022-12-31","value":66.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin75.26%51.71%44.01%62.96%73.50%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.71,"profit":true},{"date":"2021-12-31","value":58.48,"profit":true},{"date":"2022-12-31","value":83.65,"profit":true},{"date":"2023-12-31","value":97.66,"profit":true}]
Operating Expenses41.10M45.67M63.31M74.56M77.42M[{"date":"2019-12-31","value":53.09,"profit":true},{"date":"2020-12-31","value":59,"profit":true},{"date":"2021-12-31","value":81.77,"profit":true},{"date":"2022-12-31","value":96.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(22.63M)(22.12M)(39.32M)(50.51M)(41.34M)[{"date":"2019-12-31","value":-2262700000,"profit":false},{"date":"2020-12-31","value":-2211600000,"profit":false},{"date":"2021-12-31","value":-3931800000,"profit":false},{"date":"2022-12-31","value":-5050600000,"profit":false},{"date":"2023-12-31","value":-4134200000,"profit":false}]
Total Non-Operating Income/Expense(11.05M)(16.00M)(6.73M)(22.93M)(20.56M)[{"date":"2019-12-31","value":-1105200000,"profit":false},{"date":"2020-12-31","value":-1600200000,"profit":false},{"date":"2021-12-31","value":-672700000,"profit":false},{"date":"2022-12-31","value":-2293200000,"profit":false},{"date":"2023-12-31","value":-2056100000,"profit":false}]
Pre-Tax Income(30.73M)(31.35M)(43.16M)(65.45M)(52.15M)[{"date":"2019-12-31","value":-3072600000,"profit":false},{"date":"2020-12-31","value":-3135000000,"profit":false},{"date":"2021-12-31","value":-4315900000,"profit":false},{"date":"2022-12-31","value":-6544700000,"profit":false},{"date":"2023-12-31","value":-5214600000,"profit":false}]
Income Taxes629.00K5.12M1.32M14.94M5.34M[{"date":"2019-12-31","value":4.21,"profit":true},{"date":"2020-12-31","value":34.29,"profit":true},{"date":"2021-12-31","value":8.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.73,"profit":true}]
Income After Taxes(31.36M)(36.47M)(44.48M)(80.39M)(57.49M)[{"date":"2019-12-31","value":-3135500000,"profit":false},{"date":"2020-12-31","value":-3647300000,"profit":false},{"date":"2021-12-31","value":-4448000000,"profit":false},{"date":"2022-12-31","value":-8038800000,"profit":false},{"date":"2023-12-31","value":-5748510500,"profit":false}]
Income From Continuous Operations(30.73M)(31.35M)(43.16M)(65.45M)(63.34M)[{"date":"2019-12-31","value":-3072600000,"profit":false},{"date":"2020-12-31","value":-3135000000,"profit":false},{"date":"2021-12-31","value":-4315900000,"profit":false},{"date":"2022-12-31","value":-6544700000,"profit":false},{"date":"2023-12-31","value":-6334500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(31.36M)(36.47M)(44.48M)(80.39M)(52.15M)[{"date":"2019-12-31","value":-3135500000,"profit":false},{"date":"2020-12-31","value":-3647300000,"profit":false},{"date":"2021-12-31","value":-4448000000,"profit":false},{"date":"2022-12-31","value":-8038800000,"profit":false},{"date":"2023-12-31","value":-5214600000,"profit":false}]
EPS (Diluted)-(32.45)(1.54)(1.59)(0.65)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3245.5,"profit":false},{"date":"2021-12-31","value":-154,"profit":false},{"date":"2022-12-31","value":-159,"profit":false},{"date":"2023-12-31","value":-65,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BDSX
Cash Ratio 2.42
Current Ratio 3.40
Quick Ratio 3.30

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BDSX
ROA (LTM) -22.79%
ROE (LTM) -331.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BDSX
Debt Ratio Lower is generally better. Negative is bad. 0.73
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.27

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BDSX
Trailing PE NM
Forward PE NM
P/S (TTM) 3.08
P/B 7.26
Price/FCF NM
EV/R 3.55
EV/Ebitda NM

FAQs

What is Biodesix Inc share price today?

Biodesix Inc (BDSX) share price today is $1.34

Can Indians buy Biodesix Inc shares?

Yes, Indians can buy shares of Biodesix Inc (BDSX) on Vested. To buy Biodesix Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BDSX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biodesix Inc be purchased?

Yes, you can purchase fractional shares of Biodesix Inc (BDSX) via the Vested app. You can start investing in Biodesix Inc (BDSX) with a minimum investment of $1.

How to invest in Biodesix Inc shares from India?

You can invest in shares of Biodesix Inc (BDSX) via Vested in three simple steps:

  • Click on Sign Up or Invest in BDSX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biodesix Inc shares
What is Biodesix Inc 52-week high and low stock price?

The 52-week high price of Biodesix Inc (BDSX) is $2.21. The 52-week low price of Biodesix Inc (BDSX) is $1.11.

What is Biodesix Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biodesix Inc (BDSX) is

What is Biodesix Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biodesix Inc (BDSX) is 7.26

What is Biodesix Inc dividend yield?

The dividend yield of Biodesix Inc (BDSX) is 0.00%

What is the Market Cap of Biodesix Inc?

The market capitalization of Biodesix Inc (BDSX) is $202.20M

What is Biodesix Inc’s stock symbol?

The stock symbol (or ticker) of Biodesix Inc is BDSX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top